Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Am J Gastroenterol. 2022 Dec 23;118(7):1214–1225. doi: 10.14309/ajg.0000000000002125

Figure 3: Cumulative Incidence of Key Serologic Endpoints.

Figure 3:

Figure 3:

A: The cumulative percentage achieving HBsAg loss at week 240 was 5·3% in the TDF+PegIFN group and 4·1% in the TDF alone group (p=0·66).

B: The cumulative percentage achieving HBeAg loss at week 240 was 66·2% in the TDF+PegIFN group and 46·2% in the TDF alone group (p=0·009).